2.15pm – 3.15pm GMT, 26 November 2025 ‐ 1 hour
Presentation
A popular regular feature of the conference is the early career poster flash session where selected bursary winners will take to the stage with a short oral presentation.Director of Biologics & RNA Centre of Excellence, CPI
Dr. Brendan Fish is a distinguished leader in the biopharmaceutical industry with over 30 years of experience spanning biologics development, manufacturing, and regulatory strategy. He currently serves as Director of the Biologics and RNA Centre of Excellence at CPI, where he leads a multidisciplinary team and oversees state-of-the-art facilities supporting end-to-end biopharmaceutical development—from strain characterisation to GMP production.
Brendan has held senior leadership roles at GSK and MedImmune, where he was instrumental in the development, scale-up, and commercialisation of numerous biologics, including monoclonal antibodies, fusion proteins, and oligonucleotides. His expertise encompasses process development, formulation, analytical sciences, and regulatory submissions, with a proven track record of successful product launches and regulatory inspections, including FDA and MHRA.
He is a trusted advisor across industry and government, currently serving on the MHRA’s Commission on Human Medicines’ Cancer Vaccines Expert Working Group, and contributing to multiple national and academic advisory boards. Brendan is also a published scientist and patent holder, with a strong commitment to mentoring and advancing the next generation of biopharmaceutical professionals.